Latest / Eyewire News: The Podcast

Tryptyr Now Available in US
Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.